Additional file 2 of Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
- Kana Kurokawa (9538736)
- Yoichiro Mitsuishi (12296507)
- Naoko Shimada (19632)
- Yuta Kawakami (7343876)
- Keita Miura (12296504)
- Taichi Miyawaki (11732661)
- Tetsuhiko Asao (12296495)
- Ryo Ko (3488300)
- Takehito Shukuya (428397)
- Rina Shibayama (10208574)
- Shuko Nojiri (6596244)
- Kazuhisa Takahashi (118725)
Publication date
October 2022
DOIAbstract
Additional file 2: Supplementary figure S1. IrAEs and survival. Kaplan–Meier curves for overall survival in patients treated with pembrolizumab and chemotherapy (a) and those treated with pembrolizumab monotherapy (b)
Add to ORKG